Skip to main content

Table 4 Studies reporting on cost-effectiveness of palliative care interventions

From: Evidence on the economic value of end-of-life and palliative care interventions: a narrative review of reviews

Author

Cost-effectiveness

Type of intervention

Ankuda, and Meier., 2018

Reported benefits of palliative care consultations on patient outcomes, use of healthcare and costs.

Hospital-based palliative care consultations

Bradley et al.,2018

Reported some evidence of cost-effectiveness of psychosocial support on survival in women with breast cancer. No significant difference in healthcare resource use between the intervention and control groups was found.

Clinical nurse specialists

Brereton et al., 2017

Various home-based interventions showed benefits for patients and caregivers and reduced healthcare costs.

Home-based

Candy et al., 2011

Hospice care interventions reduce resource use and costs, improve pain management, and increase death outside the hospital.

Hospice care at home, nursing homes and hospice facilities

Douglas et al., 2003

Reported lower costs and greater benefits of CNSs compared to usual care. Evidence of cost-effectiveness of pain management strategies in advanced cancer patients.

Clinical nurse specialists

Gomes et al., 2013

Reported clear cost-effectiveness of home-based interventions compared to usual care in 2 studies.

Home-based

Higginson et al., 2003

Evidence of the cost-effectiveness of home-based teams for specific patient groups including cancer and AIDS.

Home-based

Meads, D.M., et al.2019

Evidence from RCTs Educational and monitoring/feedback interventions have the potential to be cost-effective in patients with advanced cancer.

Hospital-based

Salamanca-Balen et al., 2018

Inconclusive evidence suggesting cost-effectiveness of CNS interventions including improvement in health economic outcomes, mainly in cardiac patients (heart failure) in Austria, UK and Netherlands.

Clinical nurse specialists

Smith et al., 2014

Reported one cost-effectiveness that showed short-term palliative care in multiple sclerosis patients showed d potential cost-effectiveness when caregiver burden was used as the main outcome measure.

Short-term palliative care